The global Dental Membranes And Bone Graft Substitutes Market is estimated to be valued at USD 1.4 Bn in 2024 and with CAGR of 8% over the forecast period 2024-2031. The market is witnessing high growth owing to the rising prevalence of oral dental disorders and Growing Awareness about Oral Healthcare.
Market Dynamics:
The global dental membranes and bone graft substitutes market growth is driven by the increasing cases of edentulism and rising number of dental implant procedures. According to the World Health Organization, severe periodontitis prevalence is expected to reach around 8% of the global population by 2025. This is increasing the demand for dental bone grafting and tooth/jaw reconstruction, thereby propelling market growth. Moreover, growing healthcare expenditure and rising dental tourism in developing countries are favoring adoption of advanced dental biomaterials. However, high cost of dental membrane and bone graft substitute procedures along with limited reimbursement policies in some nations may restrict market expansion to some extent over the forecast period.
Growing Awareness about Oral Healthcare Promoting the Use of Dental Membranes and Bone Graft Substitutes
One of the major drivers for the global dental membranes and bone graft substitutes market is the growing awareness about oral healthcare. More and more people are realizing the importance of maintaining good oral hygiene and treating dental issues. There is understanding that conditions like gum disease and tooth loss can negatively impact overall health. As a result, people are paying greater attention to dental checkups and treatments. This increase in dental care is propelling the demand for membranes and bone graft substitutes which are used in procedures like dental implant placement, bone/socket preservation after tooth extraction, and guided bone/tissue regeneration. Various awareness campaigns by dental associations and government organizations about oral healthcare are helping bring more patients into the dental clinics.
Increasing Incidence of Accidental Tooth Loss and Periodontal Diseases Boosting Market Growth
Another key market driver is the rising incidence of accidental tooth loss and periodontal diseases globally. Road accidents, injuries during sports, and trauma can lead to tooth avulsion or tooth fracture. The number of such dental trauma cases has been on the rise. Similarly, tooth loss due to chronic conditions like periodontitis is also increasing owing to risk factors like aging population, diabetes, and pollution levels. Membranes and bone grafts are extensively used during dental implant placement and alveolar ridge preservation after tooth removal caused by trauma or periodontal disease. The growing patient base of such conditions is positively impacting the sales of these products.
Lack of Reimbursement for Dental Procedures Hindering Wider Adoption
One major restraint for the global dental membranes and bone graft substitutes market is the lack of comprehensive insurance coverage or reimbursement for dental procedures. Unlike medical healthcare, dental insurance does not cover a wide range of restorative and aesthetic treatments. This acts as a financial deterrent for many patients who may require bone grafting or membrane placement but refrain from it due to high out-of-pocket costs. Even procedures like dental implants which are considered medically necessary do not have adequate reimbursement schemes. This reimbursement gap needs to be filled to allow more patients to opt for advanced regenerative treatments.
High Cost of Membranes and Bone Grafts Limiting Their Use
The high cost of these advanced bone graft substitutes and membrane materials is another key challenge faced by the market. While they provide clinicians with better outcomes, the price factor reduces their adoption especially in price-sensitive or value-based healthcare systems. The manufacturing processes and stringent regulatory approvals add to the overall cost. This makes it difficult for both patients and providers to choose these products over conventional autogenous bone grafts which have a lower price tag. Companies need to work on reducing production costs through process optimization and scale-up to make dental regenerative solutions more affordable.
Tissue Engineering and 3D Printing Opening New Growth Avenues
Advancements in tissue engineering and 3D printing technology offer novel opportunities for players in this market. Researchers are developing bio-inspired membranes and bone graft substitutes that can closely mimic the natural extracellular matrix (ECM) for superior tissue regeneration outcomes. 3D printing is allowing the fabrication of scaffolds customized for different defect types and patient anatomies. The possibility of developing ‘living constructs’ by integrating cells, growth factors with 3D printed designs could transform the reconstructive procedure. Companies investing in these cutting-edge technologies may gain a competitive edge.
Focus on Emerging Markets with Large Patient Populations
Emerging countries in Asia Pacific, Latin America, Middle East and Africa present lucrative expansion opportunities for market stakeholders. These regions have young demographic profiles and growing consumer bases who can invest in dental and oral healthcare. The increased focus on aesthetic and restorative dentistry is expected to drive the uptake of membranes and bone grafts as more dental specialists set up operations. Additionally, foreign players can gain by forming strategic partnerships with local manufacturers and lowering product prices to cater to the value segments in developing markets. Overall, tapping into regional markets with large untapped patient pools can help accelerate future revenues.
Key Development
- In October 2023, ZimVie Inc. global life sciences company has launched the Biotivity A/C Plus Membrane in the US. It's a growth factor-rich barrier membrane for dental applications, aiding in jaw reconstruction and implant support. This move expands ZimVie's presence in dental biomaterials, focusing on wound healing enhancement.
- In May 2022, BONESUPPORT AB, an orthobiologics company, announced the receipt of market authorization from the U.S. Food and Drug Administration for Cerament G. It is the first and sole bone graft substitute designed to fill gaps during surgical procedures and manage bone defects.
- In Marh 2022, Molecular Matrix, Inc., regenerative medicine company (MMI) has officially launched its Osteo-P Synthetic Bone Graft Substitute (BGS) designed for the musculoskeletal system. This innovative product utilizes MMI’s hyper-crosslinked carbohydrate polymer (HCCP) technology platform, initially developed to enhance stem cell research environments.
- In January 2021, Dentsply Sirona Inc., a leading dental product manufacturer, announced its acquisition of Datum Dental, Ltd., a biotechnology company. This acquisition aims to advance dental regenerative procedures, enabling dental professionals to enhance patient care significantly.
Key Players: Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings Inc., Danaher Corporation, Dentsply Sirona Inc., Institut Straumann AG, Medtronic plc, BioHorizons IPH Inc., ACE Surgical Supply Company Inc., RTI Surgical Holdings Inc., Collagen Matrix Inc., LifeNet Health, DDS Lab, Citagenix, BEGO Medical GmbH, Dentium, Kuraray Co. Ltd., NovaBone Products LLC, Olympus Terumo Biomaterials Corp, and Sunstar Suisse S.A.
